OPRX - OptimizeRx: A Small-Cap Digital Health Technology Gem With Near-Term Inflection In Profitability

• Large and growing TAM with industry tailwinds like digitalization supporting growth in demand for OptimizeRx's solutions.
• Highly scalable operating model with more than sufficient network capacity to facilitate growth in the near term.
• OptimizeRx has a strong network of large customers that provides a differentiating factor and competitive advantage to compete against other competitors in the space.
• The company has a solid balance sheet and has been growing revenue at a rapid pace, setting the stage for near term inflection in profitability.
• I initiate OptimizeRx with a price target of $48.50, implying 74% upside from current levels.

For further details see: